Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

indium In 111-CHX-A DTPA trastuzumab

(IN-dee-um … tras-TOO-zoo-mab)

A substance being studied in the imaging of breast cancer and some other types of cancer. It is made by attaching a radioactive substance called indium In 111 to the monoclonal antibody trastuzumab. Trastuzumab binds to the human growth factor receptor 2 (HER2/neu) on some breast cancer cells and on several other types of cancer cells. Indium In 111-CHX-A DTPA trastuzumab is a type of radioimmunoconjugate.

indium In 111-CHX-A DTPA trastuzumab

Search NCI's Dictionary of Cancer Terms